1 year evolution of COPD patients systemic endothelial dysfunction Source: Eur Respir J 2005; 26: Suppl. 49, 718s Year: 2005
Evaluation of endothelial dysfunction at the patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 316s Year: 2004
The role of smoking in development of endothelial dysfunction in patients with COPD in combination with AH Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment Year: 2011
New markers of endothelial dysfunction in patients with COPD Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009
New markers of endothelial dysfunction in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 143s Year: 2007
Improvement of endothelial function with allopurinol may occur in selected patients with OSA: effect of age and sex Source: Eur Respir J 2007; 29: 216-217 Year: 2007
Correction of endothelial dysfunction in patients with COPD, IPF Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010
Differences in vessel endothelium function in severe COPD and severe asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 404s Year: 2006
Assessment of endothelial dysfunction in COPD patients with different types of microcirculation disorders Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016
Determinants of endothelial function in patients with COPD Source: Eur Respir J 2013; 42: 1194-1204 Year: 2013
Arterial hypertension (AH) and endothelial function (EF) in patients with COPD Source: Annual Congress 2011 - COPD mechanisms Year: 2011
Association between right heart failure and endothelial dysfunction in COPD patients Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020
Systemic endothelial dysfunction in COPD patients – study on 60 cases Source: Eur Respir J 2004; 24: Suppl. 48, 61s Year: 2004
Correlation between muscular dysfunction and vascular inflammation in COPD Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013
The impact of long-term conventional treatment for overlap syndrome (OSA and COPD) on concurrent erectile dysfuction (ED) Source: Eur Respir J 2006; 28: Suppl. 50, 198s Year: 2006
Indacaterol/glycopyrronium (IND/GLY) improves lung function irrespective of gender baseline differences in patients with COPD: A pooled analysis from the IGNITE Program Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016
LATE-BREAKING ABSTRACT: A large airway phenotype among symptomatic smokers with preserved pulmonary function: The subpopulations and intermediate outcome measures in COPD study (SPIROMICS) Source: International Congress 2016 – Mixed-up imaging of various chest diseases Year: 2016
COPD: Left ventricular dysfunction, systemic inflammation and endothelial dysfunction Source: International Congress 2014 – Markers Year: 2014
Gender difference noted for patients with chronic obstructive pulmonary disease (COPD) by a lung information needs questionnaire (LINQ) Source: Eur Respir J 2005; 26: Suppl. 49, 513s Year: 2005
The role of endothelial dysfunction and oxidative stress in the pathogenesis of erectile dysfunction (ED) in obstructive sleep apnoea-hypopnoea syndrome (OSAHS) patients Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010